Routine FDA inspection revealed serious deficiencies in aseptic manufacturing processes. Non-conformities at the sterile manufacturing stage pose a threat to product quality, and the assessed risk to product quality and patient safety for the evaluated batches is high. A risk to patients' health or life cannot be excluded. Potential effects: infection, serious complications after parenteral administration, risk to health or life.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
FAQ
Related